Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06861621

STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers

Sponsor: University Hospital, Rouen

View on ClinicalTrials.gov

Summary

Molecular diagnosis using high throughput sequencing has become an essential part of oncogenetic care, making it possible to identify people at risk, to guide surveillance, and to direct preventive surgery and treatment. The quality of this 'precision' care depends on the quality of the interpretation of the genomic variants identified. To be usable in oncogenetics, a genomic variant must be correctly interpreted: pathogenic, benign or of uncertain significance (VSI). The impact of these DNA variants (VSI) on RNA is particularly important for interpretation. Today, due to a lack of resources, joint and systematic DNA/RNA analysis is never carried out. This has inevitably meant that a number of situations of interest have been overlooked. It is now important to go a step further and organise a visible and reliable circuit, allowing routine access to these studies for patients.

Official title: STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers in Normandy and Hauts de France

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2023-09-01

Completion Date

2025-04-01

Last Updated

2025-03-14

Healthy Volunteers

No

Conditions

Locations (2)

Service Oncogénétique Centre François Baclesse

Caen, France

Clinique de génétique médicale Guy Fontaine de l'hopital de Flandre CHRU de Lille

Lille, France